小儿推拿治疗儿童功能性便秘:随机对照试验研究方案
本研究为随机、对照、多中心临床试验,计划纳入5家医院的176例功能性便秘患儿,随机分为小儿推拿组与Medilac-Vita组,治疗1周、随访2周,主要结局为每周自发性排便次数和每周完全自发性排便次数,旨在评估小儿推拿的疗效与安全性。
要点
- 小儿推拿是功能性便秘的潜在疗法,但缺乏高质量证据。
- 研究纳入176例患儿,随机分为小儿推拿组与Medilac-Vita组。
- 主要结局为每周自发性排便和完全自发性排便次数。
核心结论
- 本研究旨在评估小儿推拿治疗儿童功能性便秘的疗效与安全性,作者假设小儿推拿比益生菌更有效。
研究设计与样本
- 随机、对照、多中心临床试验,计划纳入5家医院的176例功能性便秘患儿,随机分为小儿推拿组和Medilac-Vita组,治疗1周、随访2周。
关键数值与推荐
- 主要结局为每周自发性排便次数和每周完全自发性排便次数。
- 次要结局为有效率、粪便性状、不适感和甘油灌肠率。
- 每周进行评估,治疗期和随访期监测不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Functional constipation (FC) is a common functional gastrointestinal disorder, which brings many negative impacts to the children's daily life. Pediatric Tuina has been proved to be a potential therapy for FC. However, the evidence for its effectiveness and safety is insufficient due to the lack of high-quality study. This study aims to evaluate the efficacy and safety of pediatric Tuina for children with FC. METHODS/DESIGN: This study is a randomized, controlled, multicentre, clinical trial. We will include 176 children with FC from five hospitals. The participants will be randomly allocated into two groups: the pediatric Tuina group and the Medilac-Vita group. This study will include a 1-week actual treatment period and a 2-week follow-up period. Primary outcomes are weekly spontaneous bowel movements and weekly complete spontaneous bowel movements. The secondary outcomes are effective rate, stool form, distress sensation, and glycerine enema rate. The assessment will be performed each week. Adverse event will be monitored in the treatment period and follow-up period. DISCUSSION: This study is designed to evaluate the efficacy and safety of pediatric Tuina for children with FC, and we hypothesize that pediatric Tuina is more effective than probiotics. It will provide reliable evidence and support for the treatment of FC by pediatric Tuina. TRIAL REGISTRATION: This protocol was registered in the Chinese Clinical Trial Registry (ChiCTR2100046485). .
引用
- Zhang X, Hu L, Li L, et al. Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail. Trials. 2022. PMID: 36064720. doi:10.1186/s13063-022-06678-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。